GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » COGS-to-Revenue

Nortem Biogroup (XPAR:MLBIO) COGS-to-Revenue : 0.08 (As of Dec. 2022)


View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup COGS-to-Revenue?

Nortem Biogroup's Cost of Goods Sold for the six months ended in Dec. 2022 was €0.56 Mil. Its Revenue for the six months ended in Dec. 2022 was €6.98 Mil.

Nortem Biogroup's COGS to Revenue for the six months ended in Dec. 2022 was 0.08.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Nortem Biogroup's Gross Margin % for the six months ended in Dec. 2022 was 91.97%.

Nortem Biogroup COGS-to-Revenue Historical Data

The historical data trend for Nortem Biogroup's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nortem Biogroup COGS-to-Revenue Chart

Nortem Biogroup Annual Data
Trend Dec21 Dec22
COGS-to-Revenue
0.17 0.08

Nortem Biogroup Semi-Annual Data
Dec21 Dec22
COGS-to-Revenue 0.17 0.08

Nortem Biogroup COGS-to-Revenue Calculation

Nortem Biogroup's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.561 / 6.983
=0.08

Nortem Biogroup's COGS to Revenue for the quarter that ended in Dec. 2022 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.561 / 6.983
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nortem Biogroup  (XPAR:MLBIO) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Nortem Biogroup's Gross Margin % for the six months ended in Dec. 2022 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0.561 / 6.983
=91.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Nortem Biogroup COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Nortem Biogroup's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Nortem Biogroup (XPAR:MLBIO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » COGS-to-Revenue
Comparable Companies
Traded in Other Exchanges
N/A
Address
Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500
Website
https://www.nortembiogroup.com
Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup (XPAR:MLBIO) Headlines

No Headlines